Article Details

ProBioGen and Vaccitech Sign License Agreement for ProBioGen's Technology Platform

Retrieved on: 2019-05-14 15:52:30

Tags for this article:

Click the tags to see associated articles and topics

ProBioGen and Vaccitech Sign License Agreement for ProBioGen's Technology Platform. View article details on hiswai:

Excerpt

<div>AGE1.CR® Duck Cell Line - Safe and Well tolerated for Large-Scale Production. BERLIN, Germany, and OXFORD, United Kingdom, May 15, 2019 ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo